Stapler vs. LigaSure in Elective Hepatic Resection
NCT01858987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138
Last updated 2017-10-09
Summary
The optimal technique of parenchymal transection in liver surgery has remained a matter of controversial debate among hepatobiliary surgeons. The optimal technique should enable secure sealing of the vascular and biliary structures that results in low intraoperative blood loss as well as low postoperative complication rates. Although numerous devices have been introduced and are used widely, high-level evidence, randomized controlled trials, that evaluate efficacy and safety of these devices are scarce. In the present randomized controlled trial two techniques of hepatic resection using vascular staplers and the LigaSure vessel sealing device are compared. While the primary endpoint is intraoperative blood loss a set of general and surgical variables will be analyzed to evaluate efficacy and safety of both methods.
Conditions
- Liver Resection
Interventions
- PROCEDURE
-
Stapler hepatectomy
Liver resection using vascular stapler for transection of the parenchyma
- PROCEDURE
-
LigaSure hepatectomy
Liver resection using LigaSure for transection of the parenchyma
- DEVICE
-
Ligasure
- OTHER
-
vascular staple
Sponsors & Collaborators
-
Heidelberg University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-02
- Primary Completion
- 2014-07-17
- Completion
- 2014-08-14
Countries
- Germany
Study Locations
More Related Trials
-
The EVARREST® Fibrin Sealant Patch Liver Study
NCT01993888 ·Status: COMPLETED ·Phase: PHASE3
-
REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study
NCT05663944 ·Status: COMPLETED ·Phase: PHASE2
-
Platelets in Liver Regeneration
NCT02113059 ·Status: UNKNOWN
-
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
NCT02443116 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
NCT01591200 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Lyophilized Plasma in Patients With Liver Disease
NCT01547078 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
NCT02297867 ·Status: COMPLETED ·Phase: PHASE1
-
Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis
NCT02705742 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection
NCT02414880 ·Status: COMPLETED ·Phase: PHASE4
-
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01220492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
NCT03357380 ·Status: COMPLETED ·Phase: PHASE1
-
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01483248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis
NCT03945487 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts
NCT02048319 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis
NCT01499459 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)
NCT00049842 ·Status: COMPLETED ·Phase: PHASE3
-
Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
NCT01379469 ·Status: TERMINATED ·Phase: PHASE2
-
Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis
NCT01412593 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis
NCT01877759 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
PeproStat Haemostat Study in Subjects Undergoing Liver Surgery
NCT02204930 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance
NCT02234440 ·Status: COMPLETED ·Phase: NA
-
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
NCT01766713 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs
NCT02327832 ·Status: UNKNOWN ·Phase: PHASE1
-
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
NCT00063232 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts
NCT05500157 ·Status: UNKNOWN ·Phase: NA